Walkey Allan J, Hogarth D Kyle, Lip Gregory Y H
Division of Pulmonary and Critical Care Medicine, The Pulmonary Center, Boston University School of Medicine, Boston, MA.
Section of Pulmonary and Critical Care Medicine, Department of Medicine, University of Chicago Medicine, Chicago, IL.
Chest. 2015 Oct;148(4):859-864. doi: 10.1378/chest.15-0358.
Atrial fibrillation (AF) that newly occurs during critical illness presents challenges for both short- and long-term management. During critical illness, patients with new-onset AF are clinically evaluated for hemodynamic instability owing to the arrhythmia as well as for potentially reversible arrhythmia triggers. Hemodynamically significant AF that persists during critical illness may be treated with heart rate or rhythm control strategies. Recent evidence suggests that patients in whom AF develops during acute illness (eg, sepsis, postoperatively) have high long-term risks for AF recurrence and for AF-associated complications, such as stroke, heart failure, and death. Therefore, we suggest increased efforts to improve communication of AF events between inpatient and outpatient providers and to reassess patients who had experienced new-onset AF during critical illness after they transition to the post-ICU setting. We describe various strategies for the assessment and long-term management of patients with new-onset AF during critical illness.
危重症期间新发生的心房颤动(AF)对短期和长期管理都构成挑战。在危重症期间,新发房颤患者需接受临床评估,以判断心律失常导致的血流动力学不稳定情况,以及潜在的可逆性心律失常触发因素。危重症期间持续存在的具有血流动力学意义的房颤,可采用心率或节律控制策略进行治疗。近期证据表明,在急性疾病(如脓毒症、术后)期间发生房颤的患者,房颤复发以及发生房颤相关并发症(如中风、心力衰竭和死亡)的长期风险较高。因此,我们建议加大力度,改善住院和门诊医护人员之间关于房颤事件的沟通,并对在危重症期间经历新发房颤、且已转入重症监护病房后环境的患者进行重新评估。我们描述了危重症期间新发房颤患者的评估和长期管理的各种策略。